首页> 外国专利> PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE

机译:预防,治疗和减少(持续)创伤后头痛

摘要

PROBLEM TO BE SOLVED: To provide methods of treating or reducing incidence of post-traumatic headache and at least one secondary symptom associated with post-traumatic headache in a subject.;SOLUTION: The composition comprising about 225 mg to about 1000 mg of a monoclonal antibody that modulates the CGRP pathway is subcutaneously or intravenously administered monthly for three months or more to a subject from a pre-filled syringe, a pre-filled syringe with a needle safety device, an injection pen, or an auto-injector.;SELECTED DRAWING: Figure 1;COPYRIGHT: (C)2020,JPO&INPIT
机译:要解决的问题:提供治疗或降低受试者的创伤后头痛和与创伤后头痛相关的至少一种继发症状的方法。解决方案:该组合物包含约225 mg至约1000 mg的单克隆抗体。从预装注射器,带针安全装置的预装注射器,注射笔或自动注射器向受试者皮下或静脉内施用可调节CGRP途径的抗体,三个月或更长时间。图纸:图1;版权:(C)2020,JPO&INPIT

著录项

  • 公开/公告号JP2020002172A

    专利类型

  • 公开/公告日2020-01-09

    原文格式PDF

  • 申请/专利权人 TEVA PHARMACEUTICALS INTERNATIONAL GMBH;

    申请/专利号JP20190167098

  • 发明设计人 MARCELO BIGAL;

    申请日2019-09-13

  • 分类号A61K39/395;A61K31/403;A61K31/4045;A61K31/4196;A61K31/422;A61K31/454;A61K45;A61P17/02;A61P25/04;A61P25/28;A61P29;A61P43;C07K16/26;

  • 国家 JP

  • 入库时间 2022-08-21 11:31:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号